World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), 



Dr. Tushita Thakur*


Depression is a major public health problem that has considerable health as well as socio-economic impact on patient, family and community.[1,2,5] Nearly 322 million people currently suffer from depression globally of which 18% are Indian,[3,4,5] Depression affects people from all socioeconomic backgrounds from early childhood to late ages and is more common among females (5.1%) than males (3.6%)[4] Conventional treatment of depression is not individualized and antidepressant choice is largely dependent on adverse effect and co-morbidities[16] It also has potentially serious side effects and is not suitable for pregnant women requiring depression treatment or those with multiple physical ailments.[24,25] Nearly half of the patients stop antidepressants due to fear of dependence or side effects.[27,28] Among those who continue treatment, nearly 30% remit, 30% show partial response and rest 40% are treatment resistant.[29,30] Published literature suggests that there is severe shortage of trained mental health professionals in India with only 0.07 psychiatrists per 100,000 populations[31] Thus, there is an unmet need for depression treatment and patients do search for alternatives. Homoeopathy is safe and cost-effective, and is well tolerated by patients with physical and mental disorders. Homoeopathy can be recommended to patients who develop intolerable side effects to first-line antidepressants, those resistant to standard treatments and augmentation strategies, those who cannot afford the cost of conventional treatment, pregnant women requiring depression treatment and those with multiple co-morbidities. Based on current evidence, Homoeopathy appears promising in treatment of depression [34 to 41]. There is a need to further strengthen the research based evidence for Homoeopathic treatment of depression through large scale, randomized controlled trials of longer follow up duration.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here